USANA HEALTH SCIENCES INC (USNA) Stock Overview
NYSE:USNA - US90328M1071 - Common Stock
USNA Key Statistics, Chart & Performance
The current stock price of USNA is 31.52 USD. In the past month the price increased by 10.57%. In the past year, price decreased by -21.83%.
USNA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UL | UNILEVER PLC-SPONSORED ADR | 23.95 | 155.63B | ||
| KVUE | KENVUE INC | 19.41 | 39.85B | ||
| EL | ESTEE LAUDER COMPANIES-CL A | 59.62 | 32.18B | ||
| ELF | ELF BEAUTY INC | 38.66 | 6.97B | ||
| BRBR | BELLRING BRANDS INC | 18.76 | 5.13B | ||
| COTY | COTY INC-CL A | 19.02 | 3.65B | ||
| IPAR | INTERPARFUMS INC | 22.14 | 3.64B | ||
| ODD | ODDITY TECH LTD-CL A | 28.04 | 3.33B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 9.13 | 1.09B | ||
| HLF | HERBALIFE LTD | 4.58 | 996.04M | ||
| OLPX | OLAPLEX HOLDINGS INC | 17.69 | 943.92M | ||
| YSG | YATSEN HOLDING LTD-ADR | N/A | 939.26M |
Related stock screener links
About USNA
Company Profile
USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. The company is headquartered in Salt Lake City, Utah and currently employs 1,700 full-time employees. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.
Company Info
USANA HEALTH SCIENCES INC
3838 West Parkway Blvd.
Salt Lake City UTAH 84120 US
CEO: Kevin G. Guest
Employees: 1700
Phone: 18019547100
USANA HEALTH SCIENCES INC / USNA FAQ
What is the stock price of USANA HEALTH SCIENCES INC today?
The current stock price of USNA is 31.52 USD. The price decreased by -1.22% in the last trading session.
What is the ticker symbol for USANA HEALTH SCIENCES INC stock?
The exchange symbol of USANA HEALTH SCIENCES INC is USNA and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is USNA stock listed?
USNA stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for USANA HEALTH SCIENCES INC stock?
6 analysts have analysed USNA and the average price target is 62.22 USD. This implies a price increase of 97.4% is expected in the next year compared to the current price of 31.52. Check the USANA HEALTH SCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is USANA HEALTH SCIENCES INC worth?
USANA HEALTH SCIENCES INC (USNA) has a market capitalization of 575.87M USD. This makes USNA a Small Cap stock.
How many employees does USANA HEALTH SCIENCES INC have?
USANA HEALTH SCIENCES INC (USNA) currently has 1700 employees.
What are the support and resistance levels for USANA HEALTH SCIENCES INC (USNA) stock?
USANA HEALTH SCIENCES INC (USNA) has a support level at 31.41 and a resistance level at 32.96. Check the full technical report for a detailed analysis of USNA support and resistance levels.
Is USANA HEALTH SCIENCES INC (USNA) expected to grow?
The Revenue of USANA HEALTH SCIENCES INC (USNA) is expected to grow by 12.33% in the next year. Check the estimates tab for more information on the USNA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy USANA HEALTH SCIENCES INC (USNA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of USNA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of USNA, evaluating the profitability, health, valuation and growth aspects
- USANA HEALTH SCIENCES INC (USNA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- USANA HEALTH SCIENCES INC (USNA) Sales and EPS estimates to see what analysts future expectations are.
- USANA HEALTH SCIENCES INC (USNA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- USANA HEALTH SCIENCES INC (USNA) Insider and Institutional Ownership to learn about the owners and their transactions.
- USANA HEALTH SCIENCES INC (USNA) Stock Chart to make your own analysis
- USANA HEALTH SCIENCES INC (USNA) Latest news and press-releases to stay up to date.
Does USANA HEALTH SCIENCES INC (USNA) stock pay dividends?
USNA does not pay a dividend.
When does USANA HEALTH SCIENCES INC (USNA) report earnings?
USANA HEALTH SCIENCES INC (USNA) will report earnings on 2025-10-20, after the market close.
What is the Price/Earnings (PE) ratio of USANA HEALTH SCIENCES INC (USNA)?
The PE ratio for USANA HEALTH SCIENCES INC (USNA) is 11.81. This is based on the reported non-GAAP earnings per share of 2.67 and the current share price of 31.52 USD. Check the full fundamental report for a full analysis of the valuation metrics for USNA.
What is the Short Interest ratio of USANA HEALTH SCIENCES INC (USNA) stock?
The outstanding short interest for USANA HEALTH SCIENCES INC (USNA) is 6.74% of its float. Check the ownership tab for more information on the USNA short interest.
USNA Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to USNA. When comparing the yearly performance of all stocks, USNA is a bad performer in the overall market: 81.63% of all stocks are doing better.
USNA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to USNA. USNA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
USNA Financial Highlights
Over the last trailing twelve months USNA reported a non-GAAP Earnings per Share(EPS) of 2.67. The EPS decreased by -6.64% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.79% | ||
| ROA | 4.64% | ||
| ROE | 6.42% | ||
| Debt/Equity | 0 |
USNA Forecast & Estimates
6 analysts have analysed USNA and the average price target is 62.22 USD. This implies a price increase of 97.4% is expected in the next year compared to the current price of 31.52.
For the next year, analysts expect an EPS growth of 2.78% and a revenue growth 12.33% for USNA